Tudor Investment Corp Cuts Stake in Travere Therapeutics

Hedge fund reduces position in biotech company by over 50%

Mar. 29, 2026 at 10:58am

Got story updates? Submit your updates here. ›

Tudor Investment Corp ET AL, a prominent hedge fund, has reduced its stake in Travere Therapeutics, Inc. (NASDAQ:TVTX) by 52.5% in the third quarter, according to a recent SEC filing. The firm now owns approximately 95,747 shares of the biopharmaceutical company's stock, down from 201,508 shares previously.

Why it matters

This move by Tudor Investment Corp, a major institutional investor, signals a shift in sentiment around Travere Therapeutics, a company focused on developing therapies for rare kidney and genetic disorders. The reduced stake could indicate concerns about the company's future performance or a reallocation of the fund's portfolio.

The details

According to the SEC filing, Tudor Investment Corp sold 105,761 shares of Travere Therapeutics during the third quarter, reducing its overall position by 52.5%. The firm now owns approximately 0.11% of the company's outstanding shares, valued at $2.288 million as of the most recent reporting period.

  • Tudor Investment Corp filed the SEC disclosure on March 29, 2026, reporting its Q3 2025 holdings.
  • The hedge fund reduced its Travere Therapeutics stake during the third quarter of 2025.

The players

Tudor Investment Corp

A prominent hedge fund that has reduced its stake in Travere Therapeutics by over 50%.

Travere Therapeutics, Inc.

A biopharmaceutical company focused on developing therapies for rare kidney and genetic disorders.

Got photos? Submit your photos here. ›

The takeaway

This reduction in Tudor Investment Corp's position in Travere Therapeutics could signal broader concerns about the biotech company's future prospects, as a major institutional investor has chosen to significantly scale back its exposure. However, the reasons behind the hedge fund's decision remain unclear, and investors will likely be watching closely to see if other large shareholders follow suit.